Baillie Gifford - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2023$14,172
+2.7%
3150.0%0.00%
Q4 2022$13,800
-34.3%
3150.0%0.00%
Q3 2022$21,000
+31.2%
3150.0%0.00%
Q2 2022$16,000
-20.0%
3150.0%0.00%
Q1 2022$20,000
-41.2%
3150.0%0.00%
Q4 2021$34,000
-2.9%
315
-8.2%
0.00%
Q3 2021$35,000
-2.8%
343
-15.1%
0.00%
Q2 2021$36,000
-12.2%
404
-5.2%
0.00%
Q1 2021$41,0004260.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders